lacosamide
Generic: lacosamide
Labeler: northstar rxllcDrug Facts
Product Profile
Brand Name
lacosamide
Generic Name
lacosamide
Labeler
northstar rxllc
Dosage Form
INJECTION
Routes
Active Ingredients
lacosamide 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
72603-263
Product ID
72603-263_1eee4107-cf4c-987c-e063-6394a90a5d3e
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA216335
DEA Schedule
cv
Listing Expiration
2026-12-31
Marketing Start
2024-07-15
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72603263
Hyphenated Format
72603-263
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lacosamide (source: ndc)
Generic Name
lacosamide (source: ndc)
Application Number
ANDA216335 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/mL
Packaging
- 10 VIAL, GLASS in 1 CARTON (72603-263-02) / 20 mL in 1 VIAL, GLASS (72603-263-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "1eee4107-cf4c-987c-e063-6394a90a5d3e", "openfda": {"nui": ["N0000008486"], "upc": ["0372603263015"], "unii": ["563KS2PQY5"], "rxcui": ["809974"], "spl_set_id": ["e969b294-48d9-42a2-a093-0ac715142460"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["NorthStar RxLLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, GLASS in 1 CARTON (72603-263-02) / 20 mL in 1 VIAL, GLASS (72603-263-01)", "package_ndc": "72603-263-02", "marketing_start_date": "20240715"}], "brand_name": "LACOSAMIDE", "product_id": "72603-263_1eee4107-cf4c-987c-e063-6394a90a5d3e", "dosage_form": "INJECTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72603-263", "dea_schedule": "CV", "generic_name": "LACOSAMIDE", "labeler_name": "NorthStar RxLLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LACOSAMIDE", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "ANDA216335", "marketing_category": "ANDA", "marketing_start_date": "20240715", "listing_expiration_date": "20261231"}